125 related articles for article (PubMed ID: 18482783)
1. Safety and immunogenicity, after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice.
Hinkula J; Hagbom M; Wahren B; Schroder U
Vaccine; 2008 Sep; 26(40):5101-6. PubMed ID: 18482783
[TBL] [Abstract][Full Text] [Related]
2. Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.
Bråve A; Hallengärd D; Schröder U; Blomberg P; Wahren B; Hinkula J
Vaccine; 2008 Sep; 26(40):5075-8. PubMed ID: 18450334
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults.
Kalams SA; Parker S; Jin X; Elizaga M; Metch B; Wang M; Hural J; Lubeck M; Eldridge J; Cardinali M; Blattner WA; Sobieszczyk M; Suriyanon V; Kalichman A; Weiner DB; Baden LR;
PLoS One; 2012; 7(1):e29231. PubMed ID: 22242162
[TBL] [Abstract][Full Text] [Related]
4. [Intranasal priming with HIV DNA vaccine and systemic boosting with recombinant vaccinia induce vigorous immune responses: experiment with mice].
Huang XG; Xu JQ; Ren L; Qiu C; Zhang N; Liu LX; Wan YM; Peng H; Shao YM
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3109-13. PubMed ID: 17313761
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of LIGHT expression plasmid enhances humoral and cellular immune responses to HIV-1 Nef in mice.
Wen J; Hao W; Fan Y; Du J; Du B; Qian M; Jiang W
Arch Virol; 2014 Jul; 159(7):1663-9. PubMed ID: 24435162
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
Jiang W; Ren L; Jin N
J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
[TBL] [Abstract][Full Text] [Related]
7. Intranasal Vaccination against HIV-1 with Adenoviral Vector-Based Nanocomplex Using Synthetic TLR-4 Agonist Peptide as Adjuvant.
Li M; Jiang Y; Gong T; Zhang Z; Sun X
Mol Pharm; 2016 Mar; 13(3):885-94. PubMed ID: 26824411
[TBL] [Abstract][Full Text] [Related]
8. Maternal immune status influences HIV-specific immune responses in pups after DNA prime protein boost using mucosal adjuvant.
Bråve A; Johansen K; Palma P; Benthin R; Hinkula J
Vaccine; 2008 Nov; 26(47):5957-66. PubMed ID: 18801400
[TBL] [Abstract][Full Text] [Related]
9. Chitin Micro-Particles (CMP): a useful adjuvant for inducing viral specific immunity when delivered intranasally with an HIV-DNA vaccine.
Hamajima K; Kojima Y; Matsui K; Toda Y; Jounai N; Ozaki T; Xin KQ; Strong P; Okuda K
Viral Immunol; 2003; 16(4):541-7. PubMed ID: 14733740
[No Abstract] [Full Text] [Related]
10. Improvement in T helper 1-related immune responses in BALB/c mice immunized with an HIV-1 gag plasmid combined with a chimeric plasmid encoding interleukin-18 and flagellin.
Chen YL; Chen YS; Hung YC; Liu PJ; Tasi HY; Ni WF; Hseuh PT; Lin HH
Microbiol Immunol; 2015 Aug; 59(8):483-94. PubMed ID: 26094825
[TBL] [Abstract][Full Text] [Related]
11. Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses.
Huang X; Liu L; Ren L; Qiu C; Wan Y; Xu J
Vaccine; 2007 Dec; 25(52):8874-84. PubMed ID: 18061316
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.
Jiang JQ; Patrick A; Moss RB; Rosenthal KL
J Virol; 2005 Jan; 79(1):393-400. PubMed ID: 15596832
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of HIV-1 subtype C vaccine constructs induced immune response in mice by CpG motif 1826-ODN.
Aggarwal P; Pandey RM; Seth P
Viral Immunol; 2005; 18(1):213-23. PubMed ID: 15802966
[TBL] [Abstract][Full Text] [Related]
14. Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system.
Lemiale F; Kong WP; Akyürek LM; Ling X; Huang Y; Chakrabarti BK; Eckhaus M; Nabel GJ
J Virol; 2003 Sep; 77(18):10078-87. PubMed ID: 12941918
[TBL] [Abstract][Full Text] [Related]
15. DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity.
Buonaguro L; Devito C; Tornesello ML; Schröder U; Wahren B; Hinkula J; Buonaguro FM
Vaccine; 2007 Aug; 25(32):5968-77. PubMed ID: 17629365
[TBL] [Abstract][Full Text] [Related]
16. Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.
Malm M; Rollman E; Ustav M; Hinkula J; Krohn K; Wahren B; Blazevic V
Viral Immunol; 2005; 18(4):678-88. PubMed ID: 16359234
[TBL] [Abstract][Full Text] [Related]
17. Cyclophilin A as a potential genetic adjuvant to improve HIV-1 Gag DNA vaccine immunogenicity by eliciting broad and long-term Gag-specific cellular immunity in mice.
Hou J; Zhang Q; Liu Z; Wang S; Li D; Liu C; Liu Y; Shao Y
Hum Vaccin Immunother; 2016; 12(2):545-53. PubMed ID: 26305669
[TBL] [Abstract][Full Text] [Related]
18. Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine.
Catanzaro AT; Roederer M; Koup RA; Bailer RT; Enama ME; Nason MC; Martin JE; Rucker S; Andrews CA; Gomez PL; Mascola JR; Nabel GJ; Graham BS;
Vaccine; 2007 May; 25(20):4085-92. PubMed ID: 17391815
[TBL] [Abstract][Full Text] [Related]
19. Intranasal administration of human immunodeficiency virus type-1 (HIV-1) DNA vaccine with interleukin-2 expression plasmid enhances cell-mediated immunity against HIV-1.
Xin KQ; Hamajima K; Sasaki S; Honsho A; Tsuji T; Ishii N; Cao XR; Lu Y; Fukushima J; Shapshak P; Kawamoto S; Okuda K
Immunology; 1998 Jul; 94(3):438-44. PubMed ID: 9767429
[TBL] [Abstract][Full Text] [Related]
20. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration.
Barouch DH; Santra S; Steenbeke TD; Zheng XX; Perry HC; Davies ME; Freed DC; Craiu A; Strom TB; Shiver JW; Letvin NL
J Immunol; 1998 Aug; 161(4):1875-82. PubMed ID: 9712056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
